Study finds FIT misses more cancers and precancerous lesions in women at standard threshol ...

"I'm sorry. I've made a mess..."In care settings, there are times when users accidentally soil themselves.At such times, ...

In this [Real🐾LeoCoco] magazine, I post about the daily lives of my real-life 🐾 Coco-pun and Leo-pon, who serve as the ...

Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...

A large screening study across 13 regions of Shandong Province, China, finds that a fecal immunochemical test threshold of 25 µg/g detects 96.4% of colorectal cancers while cutting the colonoscopy ...

Identify high-growth segments, refine market-entry and expansion plans, benchmark competitors, and build targeted investment strategies.Dublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- "United States General ...

Welcoming a new kitten into the household reveals the amusing and surprising ways they transform everyday objects into their ...

Fecal immunochemical tests appear more sensitive to colorectal cancer and advanced precancerous lesions in men than women, ...

Guardant Health's Shield blood test achieved 99% real-world adherence in two rural clinics, far exceeding typical 28-71% ...

Stool-based colorectal cancer (CRC) screening involves a two-step approach for those with a positive test that includes a ...

New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in prostate ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators presented new data showing the critical role of blood-based testing ...